search
Back to results

Liberal Oxygenation Versus Conservative Oxygenation in ARDS (LOCO2)

Primary Purpose

Acute Respiratory Distress Syndrome, Intensive Care

Status
Unknown status
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
Modulation of Inspired Fraction of Oxygen (FiO2)
Sponsored by
Centre Hospitalier Universitaire de Besancon
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acute Respiratory Distress Syndrome focused on measuring Oxygen

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Major patients with mechanical ventilation
  • ARDS according to Berlin definition:Hypoxemia defined with PaO2 FiO2 ratio less or equal to 300 mmHg with Positive End Expiratory Pressure higher or equal to 5 cmH20, Less than seven days between a known clinical insult or new or worsening of respiratory symptoms, Bilateral opacities on chest Imaging not fully explained by effusions, lobar or lung collapse, or nodules, Respiratory failure not fully explained by cardiac failure or fluid overload
  • Less than twelve hours following initiation of mechanical ventilation.

Exclusion Criteria:

  • Pregnancy
  • Patient less than 18 years old
  • Sickle cell disease
  • Patient deprived of freedom, Under a legal protective measure
  • Cardiac arrest as the reason for ICU hospitalisation
  • Traumatic brain injury as the reason for ICU hospitalisation
  • Hemoptysis with embolization or surgery
  • Extracorporeal life support or Extracorporeal Membrane Oxygenation before randomization
  • Chronic Obstructive Pulmonary Disease with oxygen or non invasive ventilation at home (obstructive sleep apnoea syndrome is not an exclusion criteria)
  • Patient with very high risk of death with IGS II (Simplified Severity Index II) than 90
  • Indication of hyperbaric oxygenation : carbon monoxide intoxication, gas embolism, necrotizing fasciitis
  • Cyanide intoxication, methemoglobinemia
  • Untreated pneumothorax
  • Lymphangitis carcinomatosa
  • Eosinophilic pneumonia
  • Intensive care management for organ donation
  • Participation in another interventional study with mortality as a major outcome to avoid confounding factor
  • Patient not affiliated to social security

Sites / Locations

  • BARROT Loïc

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Liberal Oxygenation (LO) group

Conservative Oxygenation (CO) group

Arm Description

A modulation of inspired fraction of oxygen will be performed with an objective of PaO2 between 90 to 105 mmHg that will be checked on arterial blood gases (ABG). Between these measurements, SpO2 will be kept more or equal to 96 percent. Alarms will be set at 95 percent for SpO2.

A modulation of inspired fraction of oxygen will be performed with an objective of PaO2 between 55 to 70 mmHg that will be checked on arterial blood gases. Between these measurements, SpO2 will be kept between 88 and 92 percent. Alarms will be set between 87 and 93 percent for SpO2.

Outcomes

Primary Outcome Measures

Death

Secondary Outcome Measures

Death
Days free of mechanical ventilation in ICU
Sequential Organ Failure Assessment (SOFA) Score
Sepsis-related Organ Failure Score
Score of morbidity
This score is based on three points: need for mechanical ventilation, need for Morbidity are renal replacement therapy, need of catecholamine or need for ventilation
Ventilator associated pneumonia
Septicemia
Antibiotic consumption
Number of days exposed to antibiotics divided by the number of days spent in ICU
Cardiovascular complications
New onset of rhythm disorders, cardiac ischemia and dose of catecholamin at 28 and 90 days
Neurological evolution
Neurological evolution measured with daily Richmond Agitation Sedation Scale score, seizures, new stroke, daily sedation doses, neuroleptic administration
Respiratory autonomy
Need for oxygen or mechanical ventilation support

Full Information

First Posted
February 25, 2016
Last Updated
July 11, 2019
Sponsor
Centre Hospitalier Universitaire de Besancon
search

1. Study Identification

Unique Protocol Identification Number
NCT02713451
Brief Title
Liberal Oxygenation Versus Conservative Oxygenation in ARDS
Acronym
LOCO2
Official Title
Liberal Oxygenation Versus Conservative Oxygenation in Patients With Acute Respiratory Distress Syndrome : Impact on Mortality (LOCO2 Study)
Study Type
Interventional

2. Study Status

Record Verification Date
November 2018
Overall Recruitment Status
Unknown status
Study Start Date
June 2016 (Actual)
Primary Completion Date
May 31, 2019 (Actual)
Study Completion Date
September 28, 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire de Besancon

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
No clear recommendation exists for the level of oxygenation of intensive care patients. In Acute Respiratory Distress Syndrome (ARDS), pulsed oxymetry (SpO2) have to be kept between 88 and 95 percent and oxygen alveolar pressure between 55 and 80 mmHg (PaO2). These recommendations are common but do not lie on high scientific knowledge and level of proof. In the major studies of these fifteen last years that changed ARDS management, PaO2 was kept around 85 and 90 mmHg despite current recommendations of 55 to 80 mmHg of PaO2. Many recent review and cohort studies pointed the risk of excessive oxygenation especially following cardiac arrest, stroke or traumatic brain injury. However, these data come in majority from cohort or database study without strong definition of hyperoxia. Data coming from prospective studies are scarce and tend to show better outcome of patients with lower objectives of oxygenation in ICU. High oxygen (O2) level may be deleterious especially on inflammatory lungs. It could enhance injuries due to mechanical ventilation. O2 could be responsable of " hyperoxia induced lung injury ". The investigators showed in a precedent study that comparing a restrictive oxygenation versus a liberal oxygenation was feasable and do not expose patients to major adverse events. More, mortality at 60 days has tendency to be lower. The investigators therefore ask if a lower objectives of PaO2 in comparison with the level usually seen in last studies on ARDS could improve ARDS patients outcome. The aim of this study is to show that a restrictive oxygenation in comparison with a liberal oxygenation strategy in patients with ARDS would lower mortality at 28 days.
Detailed Description
It is a prospective, comparative, randomized, multicentric, french, open study. Patients with ARDS will be enrolled and will be allocated to Liberal Oxygenation arm (LO) or to Conservative Oxygenation arm (CO) during the invasive mechanical ventilation procedure in ICU. In LO arm, objective of PaO2 is 90 to 105 mmHg. In CO arm, objective of PaO2 is 55 to 70 mmHg.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Respiratory Distress Syndrome, Intensive Care
Keywords
Oxygen

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
206 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Liberal Oxygenation (LO) group
Arm Type
Active Comparator
Arm Description
A modulation of inspired fraction of oxygen will be performed with an objective of PaO2 between 90 to 105 mmHg that will be checked on arterial blood gases (ABG). Between these measurements, SpO2 will be kept more or equal to 96 percent. Alarms will be set at 95 percent for SpO2.
Arm Title
Conservative Oxygenation (CO) group
Arm Type
Experimental
Arm Description
A modulation of inspired fraction of oxygen will be performed with an objective of PaO2 between 55 to 70 mmHg that will be checked on arterial blood gases. Between these measurements, SpO2 will be kept between 88 and 92 percent. Alarms will be set between 87 and 93 percent for SpO2.
Intervention Type
Drug
Intervention Name(s)
Modulation of Inspired Fraction of Oxygen (FiO2)
Intervention Description
In the two groups, if patient is not in the range of arterial oxygen pressure (PaO2), Inspired Fraction of Oxygen (FiO2) will be modified from 5 percent if difference between target is less than 5 mmHg and from 10 percent if difference from target is higher. A new arterial blood gases (ABG) will be performed 30 minutes later to check for the oxygen target range. When ABG are performed, pulsed oxymetry is compared with arterial saturation (SaO2) to adapt survey. Between each ABG, FiO2 is modified from 5 percent to 5 percent each five minutes until reaching good pulsed oxygen saturation (SpO2) target (that can be modified in function of the comparison of arterial oxygen saturation (SaO2 and SpO2 with ABG). This management of FiO2 will be done until extubation of the patient.
Primary Outcome Measure Information:
Title
Death
Time Frame
Day 28
Secondary Outcome Measure Information:
Title
Death
Time Frame
Day 90
Title
Days free of mechanical ventilation in ICU
Time Frame
Day 28
Title
Sequential Organ Failure Assessment (SOFA) Score
Description
Sepsis-related Organ Failure Score
Time Frame
Day 0, 3 and 7
Title
Score of morbidity
Description
This score is based on three points: need for mechanical ventilation, need for Morbidity are renal replacement therapy, need of catecholamine or need for ventilation
Time Frame
Day 28
Title
Ventilator associated pneumonia
Time Frame
Day 28
Title
Septicemia
Time Frame
Day 28
Title
Antibiotic consumption
Description
Number of days exposed to antibiotics divided by the number of days spent in ICU
Time Frame
Day 28
Title
Cardiovascular complications
Description
New onset of rhythm disorders, cardiac ischemia and dose of catecholamin at 28 and 90 days
Time Frame
Day 28 and day 90
Title
Neurological evolution
Description
Neurological evolution measured with daily Richmond Agitation Sedation Scale score, seizures, new stroke, daily sedation doses, neuroleptic administration
Time Frame
Day 28
Title
Respiratory autonomy
Description
Need for oxygen or mechanical ventilation support
Time Frame
Day 28 and 90

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Major patients with mechanical ventilation ARDS according to Berlin definition:Hypoxemia defined with PaO2 FiO2 ratio less or equal to 300 mmHg with Positive End Expiratory Pressure higher or equal to 5 cmH20, Less than seven days between a known clinical insult or new or worsening of respiratory symptoms, Bilateral opacities on chest Imaging not fully explained by effusions, lobar or lung collapse, or nodules, Respiratory failure not fully explained by cardiac failure or fluid overload Less than twelve hours following initiation of mechanical ventilation. Exclusion Criteria: Pregnancy Patient less than 18 years old Sickle cell disease Patient deprived of freedom, Under a legal protective measure Cardiac arrest as the reason for ICU hospitalisation Traumatic brain injury as the reason for ICU hospitalisation Hemoptysis with embolization or surgery Extracorporeal life support or Extracorporeal Membrane Oxygenation before randomization Chronic Obstructive Pulmonary Disease with oxygen or non invasive ventilation at home (obstructive sleep apnoea syndrome is not an exclusion criteria) Patient with very high risk of death with IGS II (Simplified Severity Index II) than 90 Indication of hyperbaric oxygenation : carbon monoxide intoxication, gas embolism, necrotizing fasciitis Cyanide intoxication, methemoglobinemia Untreated pneumothorax Lymphangitis carcinomatosa Eosinophilic pneumonia Intensive care management for organ donation Participation in another interventional study with mortality as a major outcome to avoid confounding factor Patient not affiliated to social security
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Loïc Barrot, MD
Organizational Affiliation
BESANCON
Official's Role
Principal Investigator
Facility Information:
Facility Name
BARROT Loïc
City
Besancon
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
26334785
Citation
Panwar R, Hardie M, Bellomo R, Barrot L, Eastwood GM, Young PJ, Capellier G, Harrigan PW, Bailey M; CLOSE Study Investigators; ANZICS Clinical Trials Group. Conservative versus Liberal Oxygenation Targets for Mechanically Ventilated Patients. A Pilot Multicenter Randomized Controlled Trial. Am J Respir Crit Care Med. 2016 Jan 1;193(1):43-51. doi: 10.1164/rccm.201505-1019OC.
Results Reference
result
PubMed Identifier
32160661
Citation
Barrot L, Asfar P, Mauny F, Winiszewski H, Montini F, Badie J, Quenot JP, Pili-Floury S, Bouhemad B, Louis G, Souweine B, Collange O, Pottecher J, Levy B, Puyraveau M, Vettoretti L, Constantin JM, Capellier G; LOCO2 Investigators and REVA Research Network. Liberal or Conservative Oxygen Therapy for Acute Respiratory Distress Syndrome. N Engl J Med. 2020 Mar 12;382(11):999-1008. doi: 10.1056/NEJMoa1916431.
Results Reference
derived

Learn more about this trial

Liberal Oxygenation Versus Conservative Oxygenation in ARDS

We'll reach out to this number within 24 hrs